Skip to main content
. Author manuscript; available in PMC: 2025 Aug 1.
Published in final edited form as: ACS Chem Neurosci. 2022 Nov 9;13(23):3281–3290. doi: 10.1021/acschemneuro.2c00342

Figure 2.

Figure 2.

2N4R Tau phosphorylation frequencies in AD patient brain tissues. Only significant AD patient frequency sites (>10%) are shown. Data used for this figure were from Wesseling et al., 2022.15 The phosphorylation sites used for antibody screening in this study are highlighted in red.